Rituxan (rituximab) has a long half-life, meaning it stays in the body for quite a while after an infusion. On average, it can remain detectable in the bloodstream for several months — typically around 6 to 9 months after the last dose, though this can vary from person to person.
A few factors that influence how long it Show Full Answer
Rituxan (rituximab) has a long half-life, meaning it stays in the body for quite a while after an infusion. On average, it can remain detectable in the bloodstream for several months — typically around 6 to 9 months after the last dose, though this can vary from person to person.
A few factors that influence how long it stays in your system include:
- Your body weight and size
- The number of doses received
- Your overall kidney and liver function
- How your immune system responds to the drug
Because Rituxan targets CD20 proteins on B cells, its effects on your immune system — particularly lower B cell counts — can persist even longer than the drug itself is detectable.
This is worth keeping in mind because a suppressed immune system means a higher risk of infection during and after treatment. It's always a good idea to flag any signs of infection (like fever, chills, or feeling generally unwell) to your care team promptly.
For the most accurate picture of how Rituxan is behaving in *your* body specifically, your oncologist or hematologist is the best person to ask — they can look at your bloodwork and give personalized guidance.
August 9
Join
Your Privacy Choices
